Endothelial microparticles mediate inflammation‐induced vascular calcification

Stimulation of endothelial cells (ECs) with TNF‐α causes an increase in the expression of bone morphogenetic protein‐2 (BMP‐2) and the production of endothelial microparticles (EMPs). BMP‐2 is known to produce osteogenic differentiation of vascular smooth muscle cells (VSMCs). It was found that EMPs...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The FASEB journal 2015-01, Vol.29 (1), p.173-181
Hauptverfasser: Buendía, Paula, Oca, Addy Montes, Madueño, Juan Antonio, Merino, Ana, Martín‐Malo, Alejandro, Aljama, Pedro, Ramírez, Rafael, Rodríguez, Mariano, Carracedo, Julia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 181
container_issue 1
container_start_page 173
container_title The FASEB journal
container_volume 29
creator Buendía, Paula
Oca, Addy Montes
Madueño, Juan Antonio
Merino, Ana
Martín‐Malo, Alejandro
Aljama, Pedro
Ramírez, Rafael
Rodríguez, Mariano
Carracedo, Julia
description Stimulation of endothelial cells (ECs) with TNF‐α causes an increase in the expression of bone morphogenetic protein‐2 (BMP‐2) and the production of endothelial microparticles (EMPs). BMP‐2 is known to produce osteogenic differentiation of vascular smooth muscle cells (VSMCs). It was found that EMPs from TNF‐α‐stimulated endothelial cells (HUVECs) contained a significant amount of BMP‐2 and were able to enhance VSMC osteogenesis and calcification. Calcium content was greater in VSMCs exposed to EMPs from TNF‐α‐treated HUVECs than EMPs from nontreated HUVECs (3.56 ± 0.57 vs. 1.48 ± 0.56 μg/mg protein; P < 0.05). The increase in calcification was accompanied by up‐regulation of Cbfa1 (osteogenic transcription factor) and down‐regulation of SM22α (VSMC lineage marker). Inhibition of BMP‐2 by small interfering RNA reduced the VSMC calcification induced by EMPs from TNF‐α‐treated HUVECs. Similar osteogenic capability was observed in EMPs from both patients with chronic kidney disease and senescent cells, which also presented a high level of BMP‐2 expression. Labeling of EMPs with CellTracker shows that EMPs are phagocytized by VSMCs under all conditions (with or without high phosphate, control, and EMPs from TNF‐α‐treated HUVECs). Our data suggest that EC damage results in the release of EMPs with a high content of calcium and BMP‐2 that are able to induce calcification and osteogenic differentiation of VSMCs.—Buendía, P., Montes de Oca, A., Madueño, J. A., Merino, A., Martín‐Malo, A., Aljama, P., Ramírez, R., Rodríguez, M., Carracedo, J., Endothelial microparticles mediate inflammation‐induced vascular calcification. FASEB J. 29, 173–181 (2015). www.fasebj.org
doi_str_mv 10.1096/fj.14-249706
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1808680041</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1643144229</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3727-2a9cd6bb15fd87d1ca397015088daa19c5d6abe662e1ecbb80eac151774ce0d83</originalsourceid><addsrcrecordid>eNqF0cFO3DAQxnELFcFCe-Nc5dhDs8zYjuMcKWKhEhJI0LM1sR3hlZMscQLixiPwjH0SUpb2WE6-_PRJ8zdjRwhLhEodN-slypzLqgS1wxZYCMiVVvCJLUBXPFdK6H12kNIaABBQ7bF9XgjJUcCCXZ91rh_vfAwUszbYod_QMAYbfcpa7wKNPgtdE6ltaQx99_v5JXRust5lD5TsFGnILEUbmmDfwGe221BM_sv7e8h-rc5uTy_yy6vzn6cnl7kVJS9zTpV1qq6xaJwuHVoS8wFYgNaOCCtbOEW1V4p79LauNXiyWGBZSuvBaXHIvm13N0N_P_k0mjYk62OkzvdTMqhBKw0g8WOqpEApOa9m-n1L5xApDb4xmyG0NDwZBPMnt2nWBqXZ5p751_flqZ5r_cN_-86g3ILHEP3Tf8fM6uYHB169fVIpXgH50I0s</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1643144229</pqid></control><display><type>article</type><title>Endothelial microparticles mediate inflammation‐induced vascular calcification</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Alma/SFX Local Collection</source><creator>Buendía, Paula ; Oca, Addy Montes ; Madueño, Juan Antonio ; Merino, Ana ; Martín‐Malo, Alejandro ; Aljama, Pedro ; Ramírez, Rafael ; Rodríguez, Mariano ; Carracedo, Julia</creator><creatorcontrib>Buendía, Paula ; Oca, Addy Montes ; Madueño, Juan Antonio ; Merino, Ana ; Martín‐Malo, Alejandro ; Aljama, Pedro ; Ramírez, Rafael ; Rodríguez, Mariano ; Carracedo, Julia</creatorcontrib><description>Stimulation of endothelial cells (ECs) with TNF‐α causes an increase in the expression of bone morphogenetic protein‐2 (BMP‐2) and the production of endothelial microparticles (EMPs). BMP‐2 is known to produce osteogenic differentiation of vascular smooth muscle cells (VSMCs). It was found that EMPs from TNF‐α‐stimulated endothelial cells (HUVECs) contained a significant amount of BMP‐2 and were able to enhance VSMC osteogenesis and calcification. Calcium content was greater in VSMCs exposed to EMPs from TNF‐α‐treated HUVECs than EMPs from nontreated HUVECs (3.56 ± 0.57 vs. 1.48 ± 0.56 μg/mg protein; P &lt; 0.05). The increase in calcification was accompanied by up‐regulation of Cbfa1 (osteogenic transcription factor) and down‐regulation of SM22α (VSMC lineage marker). Inhibition of BMP‐2 by small interfering RNA reduced the VSMC calcification induced by EMPs from TNF‐α‐treated HUVECs. Similar osteogenic capability was observed in EMPs from both patients with chronic kidney disease and senescent cells, which also presented a high level of BMP‐2 expression. Labeling of EMPs with CellTracker shows that EMPs are phagocytized by VSMCs under all conditions (with or without high phosphate, control, and EMPs from TNF‐α‐treated HUVECs). Our data suggest that EC damage results in the release of EMPs with a high content of calcium and BMP‐2 that are able to induce calcification and osteogenic differentiation of VSMCs.—Buendía, P., Montes de Oca, A., Madueño, J. A., Merino, A., Martín‐Malo, A., Aljama, P., Ramírez, R., Rodríguez, M., Carracedo, J., Endothelial microparticles mediate inflammation‐induced vascular calcification. FASEB J. 29, 173–181 (2015). www.fasebj.org</description><identifier>ISSN: 0892-6638</identifier><identifier>EISSN: 1530-6860</identifier><identifier>DOI: 10.1096/fj.14-249706</identifier><identifier>PMID: 25342130</identifier><language>eng</language><publisher>Bethesda, MD, USA: Federation of American Societies for Experimental Biology</publisher><subject>Annexin A5 - metabolism ; BMP‐2 osteogenic differentiation ; Bone Morphogenetic Protein 2 - antagonists &amp; inhibitors ; Bone Morphogenetic Protein 2 - genetics ; Bone Morphogenetic Protein 2 - metabolism ; Calcium - metabolism ; Cell-Derived Microparticles - metabolism ; Cell-Derived Microparticles - pathology ; Cells, Cultured ; Cellular Senescence ; Endothelial Cells - metabolism ; Endothelial Cells - pathology ; Gene Knockdown Techniques ; Human Umbilical Vein Endothelial Cells ; Humans ; HUVECs ; Inflammation - metabolism ; Inflammation - pathology ; Myocytes, Smooth Muscle - metabolism ; Myocytes, Smooth Muscle - pathology ; NF-kappa B - metabolism ; Osteogenesis ; Renal Insufficiency, Chronic - complications ; Renal Insufficiency, Chronic - metabolism ; Renal Insufficiency, Chronic - pathology ; TNF‐α ; Tumor Necrosis Factor-alpha - metabolism ; Vascular Calcification - etiology ; Vascular Calcification - metabolism ; Vascular Calcification - pathology ; VSMC calcification</subject><ispartof>The FASEB journal, 2015-01, Vol.29 (1), p.173-181</ispartof><rights>FASEB</rights><rights>FASEB.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3727-2a9cd6bb15fd87d1ca397015088daa19c5d6abe662e1ecbb80eac151774ce0d83</citedby><cites>FETCH-LOGICAL-c3727-2a9cd6bb15fd87d1ca397015088daa19c5d6abe662e1ecbb80eac151774ce0d83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1096%2Ffj.14-249706$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1096%2Ffj.14-249706$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25342130$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Buendía, Paula</creatorcontrib><creatorcontrib>Oca, Addy Montes</creatorcontrib><creatorcontrib>Madueño, Juan Antonio</creatorcontrib><creatorcontrib>Merino, Ana</creatorcontrib><creatorcontrib>Martín‐Malo, Alejandro</creatorcontrib><creatorcontrib>Aljama, Pedro</creatorcontrib><creatorcontrib>Ramírez, Rafael</creatorcontrib><creatorcontrib>Rodríguez, Mariano</creatorcontrib><creatorcontrib>Carracedo, Julia</creatorcontrib><title>Endothelial microparticles mediate inflammation‐induced vascular calcification</title><title>The FASEB journal</title><addtitle>FASEB J</addtitle><description>Stimulation of endothelial cells (ECs) with TNF‐α causes an increase in the expression of bone morphogenetic protein‐2 (BMP‐2) and the production of endothelial microparticles (EMPs). BMP‐2 is known to produce osteogenic differentiation of vascular smooth muscle cells (VSMCs). It was found that EMPs from TNF‐α‐stimulated endothelial cells (HUVECs) contained a significant amount of BMP‐2 and were able to enhance VSMC osteogenesis and calcification. Calcium content was greater in VSMCs exposed to EMPs from TNF‐α‐treated HUVECs than EMPs from nontreated HUVECs (3.56 ± 0.57 vs. 1.48 ± 0.56 μg/mg protein; P &lt; 0.05). The increase in calcification was accompanied by up‐regulation of Cbfa1 (osteogenic transcription factor) and down‐regulation of SM22α (VSMC lineage marker). Inhibition of BMP‐2 by small interfering RNA reduced the VSMC calcification induced by EMPs from TNF‐α‐treated HUVECs. Similar osteogenic capability was observed in EMPs from both patients with chronic kidney disease and senescent cells, which also presented a high level of BMP‐2 expression. Labeling of EMPs with CellTracker shows that EMPs are phagocytized by VSMCs under all conditions (with or without high phosphate, control, and EMPs from TNF‐α‐treated HUVECs). Our data suggest that EC damage results in the release of EMPs with a high content of calcium and BMP‐2 that are able to induce calcification and osteogenic differentiation of VSMCs.—Buendía, P., Montes de Oca, A., Madueño, J. A., Merino, A., Martín‐Malo, A., Aljama, P., Ramírez, R., Rodríguez, M., Carracedo, J., Endothelial microparticles mediate inflammation‐induced vascular calcification. FASEB J. 29, 173–181 (2015). www.fasebj.org</description><subject>Annexin A5 - metabolism</subject><subject>BMP‐2 osteogenic differentiation</subject><subject>Bone Morphogenetic Protein 2 - antagonists &amp; inhibitors</subject><subject>Bone Morphogenetic Protein 2 - genetics</subject><subject>Bone Morphogenetic Protein 2 - metabolism</subject><subject>Calcium - metabolism</subject><subject>Cell-Derived Microparticles - metabolism</subject><subject>Cell-Derived Microparticles - pathology</subject><subject>Cells, Cultured</subject><subject>Cellular Senescence</subject><subject>Endothelial Cells - metabolism</subject><subject>Endothelial Cells - pathology</subject><subject>Gene Knockdown Techniques</subject><subject>Human Umbilical Vein Endothelial Cells</subject><subject>Humans</subject><subject>HUVECs</subject><subject>Inflammation - metabolism</subject><subject>Inflammation - pathology</subject><subject>Myocytes, Smooth Muscle - metabolism</subject><subject>Myocytes, Smooth Muscle - pathology</subject><subject>NF-kappa B - metabolism</subject><subject>Osteogenesis</subject><subject>Renal Insufficiency, Chronic - complications</subject><subject>Renal Insufficiency, Chronic - metabolism</subject><subject>Renal Insufficiency, Chronic - pathology</subject><subject>TNF‐α</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><subject>Vascular Calcification - etiology</subject><subject>Vascular Calcification - metabolism</subject><subject>Vascular Calcification - pathology</subject><subject>VSMC calcification</subject><issn>0892-6638</issn><issn>1530-6860</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0cFO3DAQxnELFcFCe-Nc5dhDs8zYjuMcKWKhEhJI0LM1sR3hlZMscQLixiPwjH0SUpb2WE6-_PRJ8zdjRwhLhEodN-slypzLqgS1wxZYCMiVVvCJLUBXPFdK6H12kNIaABBQ7bF9XgjJUcCCXZ91rh_vfAwUszbYod_QMAYbfcpa7wKNPgtdE6ltaQx99_v5JXRust5lD5TsFGnILEUbmmDfwGe221BM_sv7e8h-rc5uTy_yy6vzn6cnl7kVJS9zTpV1qq6xaJwuHVoS8wFYgNaOCCtbOEW1V4p79LauNXiyWGBZSuvBaXHIvm13N0N_P_k0mjYk62OkzvdTMqhBKw0g8WOqpEApOa9m-n1L5xApDb4xmyG0NDwZBPMnt2nWBqXZ5p751_flqZ5r_cN_-86g3ILHEP3Tf8fM6uYHB169fVIpXgH50I0s</recordid><startdate>201501</startdate><enddate>201501</enddate><creator>Buendía, Paula</creator><creator>Oca, Addy Montes</creator><creator>Madueño, Juan Antonio</creator><creator>Merino, Ana</creator><creator>Martín‐Malo, Alejandro</creator><creator>Aljama, Pedro</creator><creator>Ramírez, Rafael</creator><creator>Rodríguez, Mariano</creator><creator>Carracedo, Julia</creator><general>Federation of American Societies for Experimental Biology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QP</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>201501</creationdate><title>Endothelial microparticles mediate inflammation‐induced vascular calcification</title><author>Buendía, Paula ; Oca, Addy Montes ; Madueño, Juan Antonio ; Merino, Ana ; Martín‐Malo, Alejandro ; Aljama, Pedro ; Ramírez, Rafael ; Rodríguez, Mariano ; Carracedo, Julia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3727-2a9cd6bb15fd87d1ca397015088daa19c5d6abe662e1ecbb80eac151774ce0d83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Annexin A5 - metabolism</topic><topic>BMP‐2 osteogenic differentiation</topic><topic>Bone Morphogenetic Protein 2 - antagonists &amp; inhibitors</topic><topic>Bone Morphogenetic Protein 2 - genetics</topic><topic>Bone Morphogenetic Protein 2 - metabolism</topic><topic>Calcium - metabolism</topic><topic>Cell-Derived Microparticles - metabolism</topic><topic>Cell-Derived Microparticles - pathology</topic><topic>Cells, Cultured</topic><topic>Cellular Senescence</topic><topic>Endothelial Cells - metabolism</topic><topic>Endothelial Cells - pathology</topic><topic>Gene Knockdown Techniques</topic><topic>Human Umbilical Vein Endothelial Cells</topic><topic>Humans</topic><topic>HUVECs</topic><topic>Inflammation - metabolism</topic><topic>Inflammation - pathology</topic><topic>Myocytes, Smooth Muscle - metabolism</topic><topic>Myocytes, Smooth Muscle - pathology</topic><topic>NF-kappa B - metabolism</topic><topic>Osteogenesis</topic><topic>Renal Insufficiency, Chronic - complications</topic><topic>Renal Insufficiency, Chronic - metabolism</topic><topic>Renal Insufficiency, Chronic - pathology</topic><topic>TNF‐α</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><topic>Vascular Calcification - etiology</topic><topic>Vascular Calcification - metabolism</topic><topic>Vascular Calcification - pathology</topic><topic>VSMC calcification</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Buendía, Paula</creatorcontrib><creatorcontrib>Oca, Addy Montes</creatorcontrib><creatorcontrib>Madueño, Juan Antonio</creatorcontrib><creatorcontrib>Merino, Ana</creatorcontrib><creatorcontrib>Martín‐Malo, Alejandro</creatorcontrib><creatorcontrib>Aljama, Pedro</creatorcontrib><creatorcontrib>Ramírez, Rafael</creatorcontrib><creatorcontrib>Rodríguez, Mariano</creatorcontrib><creatorcontrib>Carracedo, Julia</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>The FASEB journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Buendía, Paula</au><au>Oca, Addy Montes</au><au>Madueño, Juan Antonio</au><au>Merino, Ana</au><au>Martín‐Malo, Alejandro</au><au>Aljama, Pedro</au><au>Ramírez, Rafael</au><au>Rodríguez, Mariano</au><au>Carracedo, Julia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Endothelial microparticles mediate inflammation‐induced vascular calcification</atitle><jtitle>The FASEB journal</jtitle><addtitle>FASEB J</addtitle><date>2015-01</date><risdate>2015</risdate><volume>29</volume><issue>1</issue><spage>173</spage><epage>181</epage><pages>173-181</pages><issn>0892-6638</issn><eissn>1530-6860</eissn><abstract>Stimulation of endothelial cells (ECs) with TNF‐α causes an increase in the expression of bone morphogenetic protein‐2 (BMP‐2) and the production of endothelial microparticles (EMPs). BMP‐2 is known to produce osteogenic differentiation of vascular smooth muscle cells (VSMCs). It was found that EMPs from TNF‐α‐stimulated endothelial cells (HUVECs) contained a significant amount of BMP‐2 and were able to enhance VSMC osteogenesis and calcification. Calcium content was greater in VSMCs exposed to EMPs from TNF‐α‐treated HUVECs than EMPs from nontreated HUVECs (3.56 ± 0.57 vs. 1.48 ± 0.56 μg/mg protein; P &lt; 0.05). The increase in calcification was accompanied by up‐regulation of Cbfa1 (osteogenic transcription factor) and down‐regulation of SM22α (VSMC lineage marker). Inhibition of BMP‐2 by small interfering RNA reduced the VSMC calcification induced by EMPs from TNF‐α‐treated HUVECs. Similar osteogenic capability was observed in EMPs from both patients with chronic kidney disease and senescent cells, which also presented a high level of BMP‐2 expression. Labeling of EMPs with CellTracker shows that EMPs are phagocytized by VSMCs under all conditions (with or without high phosphate, control, and EMPs from TNF‐α‐treated HUVECs). Our data suggest that EC damage results in the release of EMPs with a high content of calcium and BMP‐2 that are able to induce calcification and osteogenic differentiation of VSMCs.—Buendía, P., Montes de Oca, A., Madueño, J. A., Merino, A., Martín‐Malo, A., Aljama, P., Ramírez, R., Rodríguez, M., Carracedo, J., Endothelial microparticles mediate inflammation‐induced vascular calcification. FASEB J. 29, 173–181 (2015). www.fasebj.org</abstract><cop>Bethesda, MD, USA</cop><pub>Federation of American Societies for Experimental Biology</pub><pmid>25342130</pmid><doi>10.1096/fj.14-249706</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0892-6638
ispartof The FASEB journal, 2015-01, Vol.29 (1), p.173-181
issn 0892-6638
1530-6860
language eng
recordid cdi_proquest_miscellaneous_1808680041
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Alma/SFX Local Collection
subjects Annexin A5 - metabolism
BMP‐2 osteogenic differentiation
Bone Morphogenetic Protein 2 - antagonists & inhibitors
Bone Morphogenetic Protein 2 - genetics
Bone Morphogenetic Protein 2 - metabolism
Calcium - metabolism
Cell-Derived Microparticles - metabolism
Cell-Derived Microparticles - pathology
Cells, Cultured
Cellular Senescence
Endothelial Cells - metabolism
Endothelial Cells - pathology
Gene Knockdown Techniques
Human Umbilical Vein Endothelial Cells
Humans
HUVECs
Inflammation - metabolism
Inflammation - pathology
Myocytes, Smooth Muscle - metabolism
Myocytes, Smooth Muscle - pathology
NF-kappa B - metabolism
Osteogenesis
Renal Insufficiency, Chronic - complications
Renal Insufficiency, Chronic - metabolism
Renal Insufficiency, Chronic - pathology
TNF‐α
Tumor Necrosis Factor-alpha - metabolism
Vascular Calcification - etiology
Vascular Calcification - metabolism
Vascular Calcification - pathology
VSMC calcification
title Endothelial microparticles mediate inflammation‐induced vascular calcification
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T21%3A48%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Endothelial%20microparticles%20mediate%20inflammation%E2%80%90induced%20vascular%20calcification&rft.jtitle=The%20FASEB%20journal&rft.au=Buend%C3%ADa,%20Paula&rft.date=2015-01&rft.volume=29&rft.issue=1&rft.spage=173&rft.epage=181&rft.pages=173-181&rft.issn=0892-6638&rft.eissn=1530-6860&rft_id=info:doi/10.1096/fj.14-249706&rft_dat=%3Cproquest_cross%3E1643144229%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1643144229&rft_id=info:pmid/25342130&rfr_iscdi=true